Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 445-453

  Huang, Sheng Fu ^a   Chen, Jiin Long ^a   Yeh, Ming Kung ^a   Chiang, Chiao Hsi ^a,b  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHYMOTRYPSIN A; DICHLOROMETHANE; POLYGLACTIN; PROPYLENE GLYCOL; SORBITAN LAURATE; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EVAPORATION; GLAUCOMA; IN VIVO STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PHYSICAL CHEMISTRY; SUSTAINED RELEASE PREPARATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AQUEOUS HUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; POLYGLACTIN 910; RABBITS; SOLUBILITY; SURFACE PROPERTIES; TENSILE STRENGTH; TIME FACTORS; TIMOLOL; TREATMENT OUTCOME;

EID: 30544446266     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.445     Document Type: Article

References (26)

1. Quigley, H.A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80:389-393, 1996.
2. Foster, P.J., and Johnson, G.J. Glaucoma in China: How big is the problem? Br. J. Ophthalmol. 85:1277-1282, 2001.
3. Schoenwald, R.D. Ocular drug delivery: Pharmacokinetic consideration. Clin. Pharmacokinet. 18:207-218, 1990.
4. 3H hydrochloride. J. Pharmacokinet. Biopharm. 14:175-211, 1986.
5. Chang, S.C., and Lee, V.H.L. Nasal and conjunctival contributors to the systemic absorption of topical timolol in the pigmented rabbit: Implications in the design of strategies to maximize the ratio of ocular to systemic absorption. J. Ocul. Pharmacol. 19:85-89, 1985.
6. Nelson, W.L., Fraunfelder, F.L., Sills, J.M., et al. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution. Am. J. Ophthalmol. 102:606-611, 1978.
7. Yoon, J.J., Kim, J.H., and Park, T.G. Dexamethasone-releasing biodegrable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials 24:2323-2329, 2003.
8. Luu, Y.K., Kim, K., Hsiao, B.S., et al. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J. Cont. Rel. 89:341-353, 2003.
9. Lu, D.W., Chang, C.J., Chiang, C.H., et al. Wound modulation after trabeculectomy by different formulation of antimetabolites on rabbits. J. Ocul. Pharmacol. Ther. 16:529-538, 2000.
10. Chiang, C.H., Tung, S.M., Lu, D.W., et al. In vitro and in vivo evaluation of an ocular delivery system of 5-fluorouracil microspheres. J. Ocul. Pharmacol. Ther. 17:545-553, 2001.
11. Aubert-Pouessel, A., Bibby, D.C., Venier-Julienne, M.C., et al. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm. Res. 19:1046-1051, 2002.
12. Zhou, S., Liao, X., Li, X., et al. Poly-D,L-lactide-copoly(ethylene glycol) microspheres as potential vaccine delivery systems. J. Contr. Rel. 86:195-205, 2003.
13. Kunou, N., Ogura, Y., Honda, Y., et al. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate. J. Biomed. Mater. Res. 51:635-641, 2000.
14. Eiji, S., Miho, N., Komei, O., et al. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. Invest. Ophthalmol. Vis. Sci. 44:4845-4852, 2003.
15. Wan, L.S., Heng, P.W., and Chia, G.G. Plasticizers and their effects on microencapsulation process by spray-drying in an aqueous system. J. Microencapsul. 9:53-62, 1992.
16. Andreopoulos, A.G. Plasticization of biodegradable polymers for use in controlled release. Clin. Mater. 15:89-92, 1994.
17. Chen, J.L., Yeh, M.K., and Chiang, C.H. Dichloromethane evaporative behavior during the solidifying process of ovalbumin-loaded poly(D,L-lactic-co- glycolic acid) microparticles. J. Food Drug Anal. 12:291-298, 2004.
18. Chiang, C.H., and Lin, C.H. Effects of cromakalim and nicorandil on intraocular pressure after topical administration in rabbit eyes. J. Ocul. Pharmacol. Ther. 11:195-201, 1995.
19. Chiang, C.H., Chang, T.J., Lu, D.W., et al. Intraocular pressure lowering effects of novel arylpiperazine derivatives. J. Ocul. Pharmacol. Ther. 14:313-322, 1998.
20. Chiang, C.H., Ho, J.I., and Chen, J.L. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes. J. Ocul. Pharmacol. Ther. 12:471-480, 1996.
21. Halper, L.K., Johnson-Pratt, L., Dobbins, T., et al. A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution qd and 0.5% levobunolol hydrochloride bid in patients with ocular hypertension or open-angle glaucoma. J. Ocul. Pharmncol. Ther. 18:105-113, 2002.
22. Budavari, S. The Merck Index 16th ed. Rahway, NJ: Merck & Co., 2001:1082.
23. Rowe, R.C. and Forse, S.F. The effect of plasticizer type and concentration on the incidence of bridging of intagliations on film-coated tablets. J. Pharm. Pharmacol. 33:174-175, 1981.
24. Hjortdal, J.O. Extensibility of the normo-hydrated human cornea. Acta. Ophthalmol. Scand. 73:12-17, 1995.
25. González-Méijome, J.M., González-Pérez, J., Cerviño, A., et al.. Changes in corneal structure with continuous wear of high-Dk soft contact lens: A pilot study. Optom. Vis. Sci. 80:440-446, 2003.
26. Martin A., Bustamante, P., and Chun, A.H.C. Physical Pharmacy, 4th ed. Philadelphia: Lea & Febiger, 1993:336.